Novartis
WEBNovartis. Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Information for patients and their caregivers ...
WEBPROMACTA is a thrombopoietin receptor agonist indicated: for the treatment of thrombocytopenia in adult and pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.
Career Search - Novartis
WEBCareer Search. Explore opportunities with Novartis below. Notice to applicants for US job openings. Learn More. Function. Audit & Finance. BD&L & Strategic Planning. Commercial & General Management. Communications & Public Affairs.
About - Novartis
WEBAbout | Novartis. About. Learn more about Novartis and explore our core therapeutic areas and technology platforms. Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease.
Careers - Novartis
WEBNovartis is aware of employment scams which make false use of our company name or leader’s names to defraud job seekers. Novartis does not make job offers without interview and never asks candidates for money. All our current job openings are displayed here. If you have encountered a job posting or been approached with a job offer that you ...
Patient assistance | Novartis United States of America
WEBCo-Pay Assistance. If you are a patient with commercial insurance and are finding it difficult to afford your medicines, the Novartis co-pay assistance program may be able to help. Eligible patients pay no more than USD 30 for a 30-day prescription (USD 1 per day) through retail or mail order for the vast majority of our branded products ...
WEBCustomer Interaction Center Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, NJ 07936-1080. This Authorization will expire 5 years after I sign it, or earlier if required by state law, unless I cancel it sooner. If I cancel it, I may no longer qualify for Services from Novartis or NPAF, but it will not impact my Provider’s ...
Research and development - Novartis
WEBResearch and development. We are an innovative medicines company with research and development at our core. Our R&D engine powers an industry-leading pipeline focused on delivering transformative medicines to fight disease, restore possibility and help people live life on their own terms. Researchers in Biomedical Research work across several ...
Novartis Pluvicto™ approved by FDA as first targeted radioligand ...
WEBMar 23, 2022 · Ad hoc announcement pursuant to Art. 53 LR . FDA also approved complementary diagnostic imaging agent, Locametz ®, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions 2; Metastatic prostate cancer has a 5-year survival rate of less than 30% 3; mCRPC patients who progress on multiple lines of therapy have limited treatment options
Investors - Novartis
WEBJul 18, 2024 · Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen. We have created a set of environmental, social and governance indices to …